Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete
Name | Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-263764683 |
Active Substance | abakavir, lamivudin |
Composition | svaka filmom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina |
Pharmaceutical Form | filmom obložena tableta |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-263764683-01] 10 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-263764683-02] 30 tableta u blisteru, u kutiji [HR-H-263764683-03] 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-263764683-04] 90 tableta u blisteru, u kutiji [HR-H-263764683-05] 90 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-263764683-06] |
Manufacturer | Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Teva Pharma B.V., Haarlem, Nizozemska Merckle GmbH, Ulm, Njemačka |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 10.07.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/43 |
Registration Number | 381-12-01/154-20-03 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | J05AR02 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |